MEDS
Income statement / Annual
Last year (2024), TRxADE HEALTH, Inc.'s total revenue was $136.64 K,
a decrease of 98.35% from the previous year.
In 2024, TRxADE HEALTH, Inc.'s net income was $9.07 M.
See TRxADE HEALTH, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$136.64 K |
$8.27 M |
$11.45 M |
$9.89 M |
$17.12 M |
$7.44 M |
$3.83 M |
$2.93 M |
$2.48 M |
$4.99 M |
| Cost of Revenue |
$130.64 K
|
$5.67 M
|
$6.00 M
|
$5.14 M
|
$11.42 M
|
$2.57 M
|
$449.05 K
|
$0.00
|
$16.36 K
|
$1.93 M
|
| Gross Profit |
$6.01 K
|
$2.60 M
|
$5.45 M
|
$4.75 M
|
$5.71 M
|
$4.87 M
|
$3.38 M
|
$2.93 M
|
$2.47 M
|
$3.06 M
|
| Gross Profit Ratio |
0.04
|
0.31
|
0.48
|
0.48
|
0.33
|
0.66
|
0.88
|
1
|
0.99
|
0.61
|
| Research and Development Expenses |
$2.24 M
|
$1.38 M
|
$1.16 M
|
$1.37 M
|
$662.73 K
|
$647.14 K
|
$949.95 K
|
$375.17 K
|
$286.76 K
|
$319.44 K
|
| General & Administrative Expenses |
$8.14 M
|
$8.48 M
|
$7.05 M
|
$8.81 M
|
$7.49 M
|
$4.38 M
|
$2.35 M
|
$2.27 M
|
$3.30 M
|
$3.70 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$147.63 K
|
$355.12 K
|
| Selling, General & Administrative Expenses |
$8.14 M
|
$8.48 M
|
$7.05 M
|
$8.81 M
|
$7.49 M
|
$4.38 M
|
$2.35 M
|
$2.27 M
|
$3.45 M
|
$4.05 M
|
| Other Expenses |
$4.20 M
|
$0.00
|
$0.00
|
-$1.23 M
|
$3.25 M
|
$72.08 K
|
$0.00
|
$67.50 K
|
$131.27 K
|
$0.00
|
| Operating Expenses |
$14.58 M
|
$9.86 M
|
$8.21 M
|
$8.81 M
|
$7.49 M
|
$4.38 M
|
$3.30 M
|
$2.27 M
|
$3.45 M
|
$4.05 M
|
| Cost And Expenses |
$14.71 M
|
$15.54 M
|
$14.20 M
|
$13.96 M
|
$18.90 M
|
$6.94 M
|
$3.75 M
|
$2.27 M
|
$3.47 M
|
$5.98 M
|
| Interest Income |
$135.34 K
|
$4.20 K
|
$20.99 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
-$1.34 M
|
$1.20 M
|
$336.21 K
|
$23.59 K
|
$29.39 K
|
$53.23 K
|
$57.54 K
|
$157.06 K
|
$151.50 K
|
$119.51 K
|
| Depreciation & Amortization |
$0.00
|
$1.05 M
|
$194.70 K
|
$138.91 K
|
$102.52 K
|
$94.73 K
|
$87.62 K
|
-$395.10 K
|
$8.67 K
|
$3.80 K
|
| EBITDA |
-$18.78 M |
-$11.47 M |
-$1.85 M |
-$5.15 M |
-$2.40 M |
$660.55 K |
$96.65 K |
$288.98 K |
-$984.03 K |
-$133.27 K |
| EBITDA Ratio |
-137.43
|
-1.39
|
-0.16
|
-0.52
|
-0.14
|
0.09
|
0.03
|
0.1
|
-0.4
|
-0.03
|
| Operating Income Ratio |
-137.43
|
-0.88
|
-0.24
|
-0.54
|
-0.1
|
0.08
|
-0.02
|
0.13
|
-0.4
|
-0.2
|
| Total Other Income/Expenses Net |
$28.38 M
|
-$6.46 M
|
-$362.72 K
|
-$23.59 K
|
-$29.39 K
|
-$778.17 K
|
$96.65 K
|
-$106.11 K
|
-$165.83 K
|
-$119.51 K
|
| Income Before Tax |
$9.60 M
|
-$13.72 M
|
-$3.91 M
|
-$5.32 M
|
-$2.54 M
|
-$284.43 K
|
$9.04 K
|
$288.98 K
|
-$1.17 M
|
-$1.12 M
|
| Income Before Tax Ratio |
70.26
|
-1.66
|
-0.34
|
-0.54
|
-0.15
|
-0.04
|
0
|
0.1
|
-0.47
|
-0.22
|
| Income Tax Expense |
$534.40 K
|
$0.00
|
$400.34 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.62 M
|
$130.14 K
|
| Net Income |
$9.07 M
|
-$17.84 M
|
-$4.31 M
|
-$4.11 M
|
-$2.57 M
|
-$409.73 K
|
$9.04 K
|
$288.98 K
|
-$2.76 M
|
-$1.12 M
|
| Net Income Ratio |
66.35
|
-2.16
|
-0.38
|
-0.42
|
-0.15
|
-0.06
|
0
|
0.1
|
-1.11
|
-0.22
|
| EPS |
2.69 |
-23.35 |
-7.63 |
-7.58 |
-4.99 |
-1.04 |
0.0233 |
0.81 |
-7.89 |
-3.2 |
| EPS Diluted |
2.48 |
-7.49 |
-7.63 |
-7.58 |
-4.99 |
-1.04 |
0.0233 |
0.81 |
-7.87 |
-3.2 |
| Weighted Average Shares Out |
$3.38 M
|
$764.06 K
|
$564.86 K
|
$542.45 K
|
$513.71 K
|
$395.27 K
|
$388.43 K
|
$355.06 K
|
$349.64 K
|
$349.64 K
|
| Weighted Average Shares Out Diluted |
$3.65 M
|
$764.06 K
|
$564.86 K
|
$542.45 K
|
$513.71 K
|
$395.27 K
|
$388.43 K
|
$378.74 K
|
$350.50 K
|
$349.64 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
